Literature DB >> 6256749

Prostaglandin I2 modifies both prolactin binding capacity and fluidity of mouse liver membranes.

J R Dave, R A Knazek.   

Abstract

The objective of this study was to determine if prostaglandins alter the fluidity of hepatic membranes and if this, in turn, modifies their ability to bind prolactin. Liver homogenates of adult C3H female mice incubated with 1-1000 nM prostaglandin A1, A2, B2, F1 alpha, 6-keto-F1 alpha, E1, E2, I2, or thromboxane B2 provided the 100,000 X g membrane pellets for subsequent ovine prolactin binding and membrane fluidity studies. Only membrane preparations treated with prostaglandin I2 showed an increase in specific binding of ovine prolactin. The effect (40-50%) was maximal at 100 nM prostaglandin I2 after 30 min of incubation and was due to an increase in the number of receptor sites. Under the same conditions, prostaglandin I2 induced a 17% decrease in membrane microviscosity. These data suggest that specific prostaglandins may modulate the number of prolactin receptors in vivo by modifying the fluidity of the lipid bilayer and the subsequent ease with which receptors can assume active configurations within the matrix.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6256749      PMCID: PMC350333          DOI: 10.1073/pnas.77.11.6597

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

Review 1.  Mammalian plasma membranes.

Authors:  M S Bretscher; M C Raff
Journal:  Nature       Date:  1975-11-06       Impact factor: 49.962

2.  Activation of casein synthesis by prostaglandins plus spermidine in mammary gland explants of mice.

Authors:  J A Rillema
Journal:  Biochem Biophys Res Commun       Date:  1976-05-03       Impact factor: 3.575

3.  Fluorescence depolarization studies of phase transitions and fluidity in phospholipid bilayers. 1. Single component phosphatidylcholine liposomes.

Authors:  B R Lentz; Y Barenholz; T E Thompson
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

4.  The effect of prostaglandins E1 and E2 on the human erythrocyte as monitored by spin labels.

Authors:  P G Kury; P W Ramwell; H M McConnell
Journal:  Biochem Biophys Res Commun       Date:  1974-01-23       Impact factor: 3.575

5.  Fluorescent probe analysis of the lipid architecture of natural and experimental cholesterol-rich membranes.

Authors:  J Vanderkooi; S Fischkoff; B Chance; R A Cooper
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

6.  Microviscosity and order in the hydrocarbon region of phospholipid and phospholipid-cholesterol dispersions determined with fluorescent probes.

Authors:  U Cogan; M Shinitzky; G Weber; T Nishida
Journal:  Biochemistry       Date:  1973-01-30       Impact factor: 3.162

Review 7.  Surface modulation in cell recognition and cell growth.

Authors:  G M Edelman
Journal:  Science       Date:  1976-04-16       Impact factor: 47.728

8.  Microviscosity parameters and protein mobility in biological membranes.

Authors:  M Shinitzky; M Inbar
Journal:  Biochim Biophys Acta       Date:  1976-04-16

9.  Effects of prostaglandins on RNA and casein synthesis in mammary gland explants of mice.

Authors:  J A Rillema
Journal:  Endocrinology       Date:  1976-08       Impact factor: 4.736

Review 10.  Biosynthesis and function of gangliosides.

Authors:  P H Fishman; R O Brady
Journal:  Science       Date:  1976-11-26       Impact factor: 47.728

View more
  3 in total

1.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Authors:  M Abecassis; J A Falk; L Makowka; V J Dindzans; R E Falk; G A Levy
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

2.  Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro.

Authors:  R W Whitcomb; W M Linehan; R A Knazek
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 3.  Liver cytoprotection by prostaglandins.

Authors:  J Quiroga; J Prieto
Journal:  Pharmacol Ther       Date:  1993       Impact factor: 12.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.